Différences
Ci-dessous, les différences entre deux révisions de la page.
| Les deux révisions précédentes Révision précédente Prochaine révision | Révision précédente | ||
|
acupuncture:evaluation:gyneco-obstetrique:03. dysmenorrhees [05 May 2025 14:49] Nguyen Johan [3.5. Emblemhealth (insurance provider, USA) 2017 ⊕] |
acupuncture:evaluation:gyneco-obstetrique:03. dysmenorrhees [29 Oct 2025 14:20] (Version actuelle) Nguyen Johan [1.2.6. Acupression] |
||
|---|---|---|---|
| Ligne 270: | Ligne 270: | ||
| === Moxibustion === | === Moxibustion === | ||
| + | |||
| + | |||
| + | == Song 2025 == | ||
| + | |||
| + | Song S, Chen H. Systematic review and meta-analysis of the effectiveness of moxibustion therapy for primary dysmenorrhea. Front Med (Lausanne). 2025 Feb 19;12:1545146. https://doi.org/10.3389/fmed.2025.1545146 | ||
| + | ^Backgound| Primary dysmenorrhea is a common gynecological disease. Compared with traditional Chinese medicine treatment, moxibustion has advantages as a main treatment method. Therefore, we conducted a systematic review and meta-analysis to evaluate the efficacy of simple moxibustion therapy for primary dysmenorrhea.| | ||
| + | ^Methods| Randomized controlled trials were searched from PubMed, Web of Science, Embase, The Cochrane Library, China National Knowledge Infrastructure, Wan-fang database and VIP database. In the literature included in these databases, clinical reporters evaluated the efficacy of moxibustion as the treatment for primary dysmenorrhea. All included literature was assessed for risk bias by using Risk of Bias assessment tool 2.0, and meta-analysis was conducted using Rev. Man 5.4.| | ||
| + | ^Results| The findings demonstrated that the moxibustion group exhibited a statistically significant response in comparison to the control group. The improvement observed in the Cox Menstrual Symptom Scale and the visual analogue scale score between the two groups exhibited heterogeneity, with a statistically significant difference noted. In terms of Traditional Chinese Medicine symptom scores, the experimental group demonstrated superiority over the control group. Furthermore, the progesterone levels in the moxibustion treatment were found to be higher than in the control group, while the estrogen levels in the experimental group were lower than in the control group, with a statistically significant difference observed (p < 0.05). Conversely, the levels of β-EP and PGE2 in the observation group were higher than those in the control group.| | ||
| + | ^Conclusion| Moxibustion therapy shows significantly better efficacy in treating primary dysmenorrhea. However, a large sample, multi-center, high-quality RCT is still needed to evaluate its safety and efficacy.| | ||
| + | |||
| + | |||
| + | |||
| == Xu 2022 == | == Xu 2022 == | ||
| Ligne 360: | Ligne 372: | ||
| === Acupression === | === Acupression === | ||
| + | |||
| + | |||
| + | |||
| + | == Yu 2025 == | ||
| + | |||
| + | Yu X, Liu B, Li J, Gao Y, Chen J, Qi R, Yuan Y, Liu Y. Efficacy and safety of acupressure for primary dysmenorrhea: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2025 Oct 23:103272. https://doi.org/10.1016/j.ctim.2025.103272 | ||
| + | |||
| + | ^Objective| This systematic review aimed to evaluate the existing randomized controlled trials (RCTs) for evidence of the association between using acupressure and reducing pain and related symptoms of primary dysmenorrhea (PD).| | ||
| + | ^Methods| Six electronic databases were searched for published reports on RCTs—from database inception until May 2025—that compared the use of acupressure with that of placebo acupressure, oral medication, or usual treatment and measured the intensity of menstrual pain and related symptoms. Two independent reviewers extracted and assessed the data. Risk of bias was assessed for each article; the meta-analysis was conducted according to the type of control. Results are presented as mean differences (MDs) or standardised mean differences (SMDs) and 95% confidence intervals (CIs).| | ||
| + | ^Results| In total, **23 RCTs** were included in the systematic review and data from 20 RCTs were evaluated in the meta-analysis. Most studies showed a low or unclear risk of bias. We found that using acupressure was more effective in reducing menstrual pain than using placebo acupressure (MD = -1.58; 95% CI, [-1.96, -1.20]), oral medication (MD = -1.11; 95% CI, [-1.79, -0.43]), or usual treatment (MD = -1.29; 95% CI, [-1.77, -0.80]). The adverse events, reported in only two studies, were mild.| | ||
| + | ^Conclusion| Acupressure can effectively reduce the pain and related symptoms of PD, though the current evidence is of low quality. Future studies with rigorous designs and larger sample sizes are warranted to verify the efficacy and safety of acupressure. Subsequent findings should be incorporated into clinical practice and nursing care to refine the treatment strategies for PD.| | ||
| == Armour 2019 ☆== | == Armour 2019 ☆== | ||
